Algert Global LLC Has $4.03 Million Holdings in Doximity, Inc. (NASDAQ:DOCS)

Algert Global LLC lowered its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 16.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 92,445 shares of the company’s stock after selling 17,873 shares during the period. Algert Global LLC’s holdings in Doximity were worth $4,028,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Sei Investments Co. boosted its position in shares of Doximity by 36.5% during the 1st quarter. Sei Investments Co. now owns 35,010 shares of the company’s stock worth $942,000 after acquiring an additional 9,359 shares in the last quarter. CANADA LIFE ASSURANCE Co boosted its stake in Doximity by 22.7% in the first quarter. CANADA LIFE ASSURANCE Co now owns 80,464 shares of the company’s stock valued at $2,165,000 after buying an additional 14,862 shares in the last quarter. LRI Investments LLC bought a new position in Doximity in the first quarter valued at about $34,000. Price T Rowe Associates Inc. MD raised its stake in Doximity by 0.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 559,826 shares of the company’s stock worth $15,065,000 after acquiring an additional 2,190 shares in the last quarter. Finally, Janus Henderson Group PLC lifted its holdings in shares of Doximity by 33.5% in the first quarter. Janus Henderson Group PLC now owns 2,474,695 shares of the company’s stock worth $66,594,000 after acquiring an additional 621,590 shares during the last quarter. 87.19% of the stock is owned by institutional investors and hedge funds.

Doximity Stock Up 1.1 %

Shares of NASDAQ:DOCS opened at $48.75 on Tuesday. The stock has a market cap of $9.10 billion, a price-to-earnings ratio of 56.03, a PEG ratio of 3.91 and a beta of 1.30. The business’s 50 day moving average is $44.83 and its 200 day moving average is $35.34. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $61.75.

Analyst Ratings Changes

DOCS has been the subject of a number of research reports. Canaccord Genuity Group cut Doximity from a “buy” rating to a “hold” rating and increased their price target for the company from $40.00 to $60.00 in a research note on Wednesday, November 13th. Evercore ISI lifted their price target on Doximity from $34.00 to $45.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Raymond James reiterated an “outperform” rating and issued a $65.00 price objective (up previously from $37.00) on shares of Doximity in a report on Friday, November 8th. Barclays upped their price target on shares of Doximity from $52.00 to $75.00 and gave the company an “overweight” rating in a research report on Monday, November 11th. Finally, Needham & Company LLC upgraded shares of Doximity from a “hold” rating to a “buy” rating and set a $38.00 price target on the stock in a report on Friday, August 9th. Eleven equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $52.27.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.